glp 1 and anesthesia risk Delayed gastric emptying: an unwanted effect of glucagon like peptide agonists in the perioperative setting – The Anaesthesia Collective GLP-1 drugs and aspiration risk

LIMIT PLAN EXPOSURE A Balanced Approach With ever-increasing demand for Wegovy, Zepbound and other GLP-1s, these medications present significant cost challenges to employers who struggle to balance the financial impact on their health plan with employee desire for coverage

All three peptides are prescription-only in the U.S

Employer Health Benefits and Coverage Decisions Corporate health plans show limited coverage of GLP-1 medications, with only 34% providing coverage according to 2024 data ^42

J Trace Elem Med Biol

Cell immunofluorescence staining For cell immunofluorescence microscopy, cells were seeded on 12 mm coverslips and washing by ice-cold (PBS, pH = 7.4)